Category: Medications - Page 2

Apr

Medications

Are Generic Medications Safe During Pregnancy? Data and Facts

Are generic medications safe during pregnancy? Discover the data on bioequivalence, FDA standards, and the difference between brand and generic drugs for expectant mothers.

William Blehm

Mar

Medications

Statins in Liver Disease: Safety and Cardiovascular Benefit

Explore the safety and cardiovascular benefits of statins for patients with liver disease, debunking myths about hepatotoxicity with current clinical evidence.

William Blehm

Mar

Medications

Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines

Patent litigation in the generic drug market is delaying affordable medicines. Companies use weak patents and serial lawsuits to block competition, costing billions and harming patient access.

William Blehm

Mar

Medications

Blood Thinner Bleeding: When to Seek Emergency Care

Learn the warning signs of dangerous bleeding while on blood thinners and when to rush to the ER. Know what’s an emergency, what’s manageable at home, and why stopping your medication can be more dangerous than the bleed.

William Blehm

Mar

Medications

Using Copay Cards Safely: Access Without Compromising Care

Copay cards can make life-saving medications affordable-but hidden insurance rules like accumulator programs can leave patients facing thousands in unexpected costs. Learn how to use them safely and avoid treatment disruption.

William Blehm

Mar

Medications

How to Use Patient Assistance Programs When No Generic Medication Exists

When no generic version of a medication exists, patient assistance programs can cover 100% of the cost-turning $15,000-a-month drugs into $0 out-of-pocket expenses. Learn how to apply, who qualifies, and how to avoid hidden traps like accumulator policies.

William Blehm

Mar

Medications

Long-term safety studies: comparing generics and brands over time

Long-term safety studies show generics are generally as safe as brand-name drugs, but critical differences exist for narrow therapeutic index medications. Manufacturing origin and individual response matter more than brand vs. generic labels.

William Blehm

Feb

Medications

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents

Paragraph IV patent challenges let generic drug makers legally fight brand patents to bring cheaper medicines to market faster. Under the Hatch-Waxman Act, this system has saved U.S. consumers over $1.2 trillion since 1990.

William Blehm

Feb

Medications

Opioid Withdrawal Timeline and How to Manage Symptoms Effectively

Opioid withdrawal symptoms peak within 72 hours and can last up to two weeks, depending on the drug. Medications like buprenorphine and methadone reduce symptoms by up to 70%, and medical supervision cuts relapse risk. Learn the timeline and science-backed strategies to manage withdrawal safely.

William Blehm

Feb

Medications

Proton Pump Inhibitors and Antifungals: How They Interfere With Absorption and Effectiveness

Proton pump inhibitors can severely reduce the absorption of some antifungals like itraconazole and ketoconazole, leading to treatment failure. Fluconazole is unaffected by stomach pH, but interactions with liver enzymes still matter. Emerging research shows PPIs may even boost antifungal power in resistant infections.

William Blehm

Feb

Medications

Tiered Copays: Why Your Generic Drug Might Cost More Than Expected

Your generic drug might cost more than the brand name because of how insurers tier medications. It’s not about quality - it’s about rebates. Here’s why and what to do about it.

William Blehm

Feb

Medications

How Medicare Drug Price Negotiation Works and What It Means for Your Costs

Medicare is now negotiating drug prices for the first time, cutting costs by up to 79% on 10 top medications starting in 2026. Here's how it works, who it helps, and what's coming next.

William Blehm